- Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseasesLabcorp is launching the Marker by Labcorp Genetic Health Panel, a new direct-to-consumer genetic testing tool that analyzes 163 genes to determine patients’ risk of over 100 hereditary health cond…Fierce Biotech · 1d ago↗ source
- Recon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps · 1d ago↗ source
- Researchers find similar drug development to reimbursement timelines for major markets<p>Time between a drug’s entry into clinical trials and its approval for reimbursement was similar in four major markets, according to a cross-sectional analysis published in JAMA Health Forum.</p>